Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 129 Pages
Report ld: 5344942
Request Sample
Customized Report
POCT Diagnostic Analyzer Market Size(US$)

CAGR 2025-2031
4.2%
Market Size,2031
USD 288
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global POCT Diagnostic Analyzer market is projected to grow from US$ 217 million in 2024 to US$ 288 million by 2031, at a CAGR of 4.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Point-of-care (POC) diagnostic device is an instrument that is used to acquire particular clinical information of patients in clinical as well as resource-limited settings.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global POCT Diagnostic Analyzer market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the POCT Diagnostic Analyzer study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to POCT Diagnostic Analyzer: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global POCT Diagnostic Analyzer Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Urinalysis Analyzers
1.2.3 Blood Glucose Meter
1.2.4 Clinical Chemistry Analyzers
1.2.5 Blood Gas Analyzers
1.2.6 INR Test Meter
1.2.7 Cardiac Marker Analyzers
1.2.8 Electrolyte Analyzers
1.2.9 Hemoglobin Meter
1.2.10 Other
1.3 Market Segmentation by Application
1.3.1 Global POCT Diagnostic Analyzer Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global POCT Diagnostic Analyzer Revenue Estimates and Forecasts 2020-2031
2.2 Global POCT Diagnostic Analyzer Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global POCT Diagnostic Analyzer Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global POCT Diagnostic Analyzer Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Urinalysis Analyzers Market Size by Players
3.3.2 Blood Glucose Meter Market Size by Players
3.3.3 Clinical Chemistry Analyzers Market Size by Players
3.3.4 Blood Gas Analyzers Market Size by Players
3.3.5 INR Test Meter Market Size by Players
3.3.6 Cardiac Marker Analyzers Market Size by Players
3.3.7 Electrolyte Analyzers Market Size by Players
3.3.8 Hemoglobin Meter Market Size by Players
3.3.9 Other Market Size by Players
3.4 Global POCT Diagnostic Analyzer Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global POCT Diagnostic Analyzer Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global POCT Diagnostic Analyzer Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America POCT Diagnostic Analyzer Market Size by Type (2020-2031)
6.4 North America POCT Diagnostic Analyzer Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America POCT Diagnostic Analyzer Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe POCT Diagnostic Analyzer Market Size by Type (2020-2031)
7.4 Europe POCT Diagnostic Analyzer Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe POCT Diagnostic Analyzer Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific POCT Diagnostic Analyzer Market Size by Type (2020-2031)
8.4 Asia-Pacific POCT Diagnostic Analyzer Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific POCT Diagnostic Analyzer Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America POCT Diagnostic Analyzer Market Size by Type (2020-2031)
9.4 Central and South America POCT Diagnostic Analyzer Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America POCT Diagnostic Analyzer Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa POCT Diagnostic Analyzer Market Size by Type (2020-2031)
10.4 Middle East and Africa POCT Diagnostic Analyzer Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa POCT Diagnostic Analyzer Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Getein Biotech
11.1.1 Getein Biotech Corporation Information
11.1.2 Getein Biotech Business Overview
11.1.3 Getein Biotech POCT Diagnostic Analyzer Product Features and Attributes
11.1.4 Getein Biotech POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)
11.1.5 Getein Biotech POCT Diagnostic Analyzer Revenue by Product in 2024
11.1.6 Getein Biotech POCT Diagnostic Analyzer Revenue by Application in 2024
11.1.7 Getein Biotech POCT Diagnostic Analyzer Revenue by Geographic Area in 2024
11.1.8 Getein Biotech POCT Diagnostic Analyzer SWOT Analysis
11.1.9 Getein Biotech Recent Developments
11.2 Guangzhou Wondfo Biotech
11.2.1 Guangzhou Wondfo Biotech Corporation Information
11.2.2 Guangzhou Wondfo Biotech Business Overview
11.2.3 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer Product Features and Attributes
11.2.4 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)
11.2.5 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer Revenue by Product in 2024
11.2.6 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer Revenue by Application in 2024
11.2.7 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer Revenue by Geographic Area in 2024
11.2.8 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer SWOT Analysis
11.2.9 Guangzhou Wondfo Biotech Recent Developments
11.3 EasyDiagnosis Biomedicine
11.3.1 EasyDiagnosis Biomedicine Corporation Information
11.3.2 EasyDiagnosis Biomedicine Business Overview
11.3.3 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer Product Features and Attributes
11.3.4 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)
11.3.5 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer Revenue by Product in 2024
11.3.6 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer Revenue by Application in 2024
11.3.7 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer Revenue by Geographic Area in 2024
11.3.8 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer SWOT Analysis
11.3.9 EasyDiagnosis Biomedicine Recent Developments
11.4 Roche Holding AG
11.4.1 Roche Holding AG Corporation Information
11.4.2 Roche Holding AG Business Overview
11.4.3 Roche Holding AG POCT Diagnostic Analyzer Product Features and Attributes
11.4.4 Roche Holding AG POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)
11.4.5 Roche Holding AG POCT Diagnostic Analyzer Revenue by Product in 2024
11.4.6 Roche Holding AG POCT Diagnostic Analyzer Revenue by Application in 2024
11.4.7 Roche Holding AG POCT Diagnostic Analyzer Revenue by Geographic Area in 2024
11.4.8 Roche Holding AG POCT Diagnostic Analyzer SWOT Analysis
11.4.9 Roche Holding AG Recent Developments
11.5 ABBOTT
11.5.1 ABBOTT Corporation Information
11.5.2 ABBOTT Business Overview
11.5.3 ABBOTT POCT Diagnostic Analyzer Product Features and Attributes
11.5.4 ABBOTT POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)
11.5.5 ABBOTT POCT Diagnostic Analyzer Revenue by Product in 2024
11.5.6 ABBOTT POCT Diagnostic Analyzer Revenue by Application in 2024
11.5.7 ABBOTT POCT Diagnostic Analyzer Revenue by Geographic Area in 2024
11.5.8 ABBOTT POCT Diagnostic Analyzer SWOT Analysis
11.5.9 ABBOTT Recent Developments
11.6 Siemens Healthcare
11.6.1 Siemens Healthcare Corporation Information
11.6.2 Siemens Healthcare Business Overview
11.6.3 Siemens Healthcare POCT Diagnostic Analyzer Product Features and Attributes
11.6.4 Siemens Healthcare POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)
11.6.5 Siemens Healthcare Recent Developments
11.7 BD
11.7.1 BD Corporation Information
11.7.2 BD Business Overview
11.7.3 BD POCT Diagnostic Analyzer Product Features and Attributes
11.7.4 BD POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)
11.7.5 BD Recent Developments
11.8 Quidel
11.8.1 Quidel Corporation Information
11.8.2 Quidel Business Overview
11.8.3 Quidel POCT Diagnostic Analyzer Product Features and Attributes
11.8.4 Quidel POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)
11.8.5 Quidel Recent Developments
11.9 Danaher Corp
11.9.1 Danaher Corp Corporation Information
11.9.2 Danaher Corp Business Overview
11.9.3 Danaher Corp POCT Diagnostic Analyzer Product Features and Attributes
11.9.4 Danaher Corp POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)
11.9.5 Danaher Corp Recent Developments
11.10 Abaxis
11.10.1 Abaxis Corporation Information
11.10.2 Abaxis Business Overview
11.10.3 Abaxis POCT Diagnostic Analyzer Product Features and Attributes
11.10.4 Abaxis POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 POCT Diagnostic AnalyzerIndustry Chain Analysis
12.1 POCT Diagnostic Analyzer Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 POCT Diagnostic Analyzer Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global POCT Diagnostic Analyzer Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for POCT Diagnostic Analyzer was estimated to be worth US$ 225 million in 2025 and is projected to reach US$ 299 million, growing at a CAGR of 4.2% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 103
USD 3950.00
(Single User License)
The global POCT Diagnostic Analyzer market was valued at US$ 225 million in 2025 and is anticipated to reach US$ 299 million by 2032, at a CAGR of 4.2% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 110
USD 2900.00
(Single User License)
The global POCT Diagnostic Analyzer market size was US$ 217 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
The global market for POCT Diagnostic Analyzer was estimated to be worth US$ 217 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 87
USD 3950.00
(Single User License)
The global market for POCT Diagnostic Analyzer was valued at US$ 217 million in the year 2024 and is projected to reach a revised size of US$ 288 million by 2031, growing at a CAGR of 4.2% during the forecast period.
Published Date: 2025-01-13
Pages: 80
USD 2900.00
(Single User License)
Point-of-care (POC) diagnostic device is an instrument that is used to acquire particular clinical information of patients in clinical as well as resource-limited settings.
Published Date: 2024-01-17
Pages: 86
USD 2900.00
(Single User License)
The global market for POCT Diagnostic Analyzer was estimated to be worth US$ 225 million in 2025 and is projected to reach US$ 299 million, growing at a CAGR of 4.2% from 2026 to 2032.
Published: 2026-06-16
Pages: 103
The global POCT Diagnostic Analyzer market was valued at US$ 225 million in 2025 and is anticipated to reach US$ 299 million by 2032, at a CAGR of 4.2% from 2026 to 2032.
Published: 2026-04-17
Pages: 110
The global POCT Diagnostic Analyzer market size was US$ 217 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
The global market for POCT Diagnostic Analyzer was estimated to be worth US$ 217 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 87
The global market for POCT Diagnostic Analyzer was valued at US$ 217 million in the year 2024 and is projected to reach a revised size of US$ 288 million by 2031, growing at a CAGR of 4.2% during the forecast period.
Published: 2025-01-13
Pages: 80
Point-of-care (POC) diagnostic device is an instrument that is used to acquire particular clinical information of patients in clinical as well as resource-limited settings.
Published: 2024-01-17
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now